Vanguard Group Inc Imara Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$3.73 - $5.2 $511,226 - $712,701	137,058 Added 45.06%	441,213 $1.8 Million
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.42 $42,699 - $93,092	38,468 Added 14.48%	304,155 $693,000
Q1 2022 May 13, 2022	SELL	$1.15 - $2.41 $250,949 - $525,902	-218,217 Reduced 45.1%	265,687 $500,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $2,250 - $4,050	-1,000 Reduced 0.21%	483,904 $1.09 Million
Q3 2021 Nov 12, 2021	BUY	$4.08 - $7.83 $1.2 Million - $2.3 Million	293,493 Added 153.33%	484,904 $1.98 Million
Q2 2021 Aug 13, 2021	BUY	$6.78 - $9.04 $1.3 Million - $1.73 Million	191,411 New	191,411 $1.51 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.